Article
Expansion of a bacterial operon during cancer treatment ameliorates drug toxicity
2024-06-06
Abstract excerpt
Dose-limiting toxicities remain a major barrier to drug development and therapy, revealing the limited predictive power of human genetics. Herein, we demonstrate the utility of a more comprehensive approach to studying drug toxicity through longitudinal study of the human gut microbiome during colorectal cancer (CRC) treatment ( NCT04054908 ) coupled to cell culture and mouse experiments. 16S rRNA gene sequencing...
Topics
Open a Topic to create a Post that cites this publication.
- Cancer Genomics and Diagnostics
- Clostridium difficile and Clostridium perfringens research
- Genetic factors in colorectal cancer
- Gut microbiota and health
- Lung Cancer Treatments and Mutations
- Mycobacterium research and diagnosis
- Pancreatic and Hepatic Oncology Research
- Tuberculosis Research and Epidemiology
Identifiers and source
- Literature Corpus work
- 16de2967-a3da-5650-8aaf-9aca02f0fa24
- DOI
- 10.1101/2024.06.04.597471
